BeOne Medicines (BEIGF) EBT Margin Growth (1y) (2016 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) EBT Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | -68.00 |
| 2 | AbbVie | 442.18 Bn | 435.61 Bn | 12.70 Bn | 1,510.00 |
| 3 | Merck | 366.59 Bn | 359.45 Bn | 12.21 Bn | -3,574.00 |
| 4 | Novartis Ag | 266.49 Bn | 258.80 Bn | 11.24 Bn | -261.00 |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn | -2,512.00 |
| 6 | Sanofi | 52.34 Bn | 44.96 Bn | 10.79 Bn | -504.00 |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | -101.00 |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn | -356.00 |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | 1,076.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,076.00 |
| Mar 31, 2026 | 1,526.00 |
| Dec 31, 2025 | 1,753.00 |
| Sep 30, 2025 | 2,023.00 |
| Jun 30, 2025 | 1,897.00 |
| Mar 31, 2025 | 3,426.00 |
| Dec 31, 2024 | 4,772.00 |
| Sep 30, 2024 | -3,917.00 |
| Jun 30, 2024 | 5,033.00 |
| Mar 31, 2024 | 4,286.00 |
| Dec 31, 2023 | 5,809.00 |
| Sep 30, 2023 | 17,156.00 |
| Jun 30, 2023 | 10,151.00 |
| Mar 31, 2023 | 6,214.00 |
| Dec 31, 2022 | 16,085.00 |
| Sep 30, 2022 | 6,758.00 |
| Jun 30, 2022 | 15,716.00 |
| Mar 31, 2022 | -14,759.00 |
| Dec 31, 2021 | 20,726.00 |
| Sep 30, 2021 | 26,786.00 |